A Dissertation on the Isolation, Culture, Sub-Culture and Species Identification of Candida from the Mucosal Lesions of Immunocompromised Individuals. by Rajkumar, K
 
A DISSERTATION ON THE ISOLATION, CULTURE, 
SUB-CULTURE AND SPECIES IDENTIFICATION  
OF CANDIDA FROM THE MUCOSAL LESIONS OF 
IMMUNOCOMPROMISED INDIVIDUALS 
 
 
 
 
Dissertation Submitted to 
THE TAMILNADU 
DR.M.G.R. MEDICAL UNIVERSITY 
 
 
 
in partial fulfillment of the regulations 
for the award of the degree of 
 
 
M.D. (Dermatology, Venereology and Leprology) 
BRANCH  -  XII  A 
 
 
 
 
 
 
 
 
 
MADRAS MEDICAL COLLEGE 
THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY 
CHENNAI, INDIA.  
 
MARCH  - 2008 
 DECLARATION 
 I, Dr.K.RAJKUMAR, solemnly declare that dissertation titled, 
“A DISSERTATION ON THE ISOLATION, CULTURE,  
SUB-CULTURE AND SPECIES IDENTIFICATION OF 
CANDIDA FROM THE MUCOSAL LESIONS OF 
IMMUNOCOMPROMISED INDIVIDUALS” is a bonafide work 
done by me at Madras medical college during 2006-2008 under the 
guidance and supervision of Prof. Dr. B. PARVEEN, M.D., D.D., 
Professor and Head, Department of Dermatology, Madras Medical 
College, Chennai - 600 003. 
 The dissertation is submitted to The Tamilnadu, Dr.M.G.R. 
Medical University, towards partial fulfillment of requirement for the 
award of M.D. Degree in Dermatology, Venereology and Leprology 
(BRANCH - XII A). 
 
Place : Chennai 
Date  : 
 
(Dr. K. RAJKUMAR) 
 
 
 
 
 
SPECIAL  ACKNOWLEDGEMENT 
 
 
 
I gratefully acknowledge and sincerely thank 
 
Prof. Dr. T. P. KALANITI,  M.D., 
DEAN, 
Madras Medical College and Government General Hospital,  
Chennai, 
 
for granting me permission to utilize the resources of this  
institution for my study. 
ACKNOWLEDGEMENT 
 I would like to express my most sincere thanks to the following 
persons who went the extra mile to help me complete this dissertation. 
 I express my heartiest thanks to the Professor and Head of the 
Department of Dermatology Dr.B.Parveen, M.D., D.D., for her kind 
help and advice. I express my sincere thanks to Dr.S.Jayakumar, M.D., 
D.D., Additional Professor of Dermatology for his kind help and 
support. I sincerely thank Dr.C.Janaki, M.D., D.D., Additional 
Professor of Mycology for her invaluable advice, guidance and 
encouragement throughout the study. 
 I sincerely thank the Professor and Head of the Department of 
Occupational Dermatology and Contact Dermatitis Dr.D.Prabhavathy, 
M.D., D.D.,  for her help rendered, constant motivation and support.  
 I also thank Dr.S.V.Somasundaram, M.D., D.D., Additional 
Professor, Department of Occupational Dermatology and Contact 
Dermatitis for his encouragement and timely support. 
 I would like to thank my Assistant Professors, Dr.V.Anandan, 
M.D., D.C.H., D.N.B. (Pediatrics), Dr.R.Priyavathani, M.D., D.N.B., 
(Dermatology), Dr. G.K. Tharini, M.D.,  Dr. N. Hema, M.D.,  
Dr. S. Anupama Roshan, D.D.V.L., for the immense interest shown by 
them towards the successful completion of my study. 
 I am grateful to Assistant Professors, Dr.A.Hameedullah, M.D., 
D.D., Dr.S. Kumaravel, M.D., D.D., Dr.J.Manjula, M.D., D.N.B., 
(Dermatology) and Dr.Afthab Jameela Wahab, M.D., D.D.,  for the 
encouragement given by them in doing my dissertation. 
 I sincerely thank the Director and Professor, Institute of 
Venereology, Dr.V.S.Dorairaj, M.D., D.V., for his kind help and 
guidance. I thank Additional Professor Dr.N.Kumar, M.D., D.V., 
D.M.R.D., Institute  of Venereology for his guidelines. 
 I also extend my sincere hearty thanks to Assistant Professors, 
Dr.V.Thirunavukkarasu, M.D.,D.V., Dr.K.Venkateswaran, M.D., D.V.,  
Dr.S.Thilagavathy, M.D., D.V., Dr.P.Mohan, M.D., D.V., Dr.S.Kalaivani, 
M.D., D.V., Dr.S.Arunkumar, M.D., D.V., Dr.P.Prabahar, M.D., 
(DVL), of Institute of Venereology for their able guidance. 
 I express my sincere gratitude to Dr.K.Rathinavelu, M.D., D.D.,  
Former Professor of Leprosy and Dr.R.Arunadevi, M.D., D.D., 
Lecturer / Registrar, Department of Dermatology for their support. 
 I extend my heartfelt thanks to Mr. P. Kannan, Research Scholar 
Entomological Institute, Loyola College for his timely help all through 
my study. 
 I am also grateful to my colleagues and paramedical workers for 
their kind support and timely help. 
 A special mention of thanks to the patients for their co-operation 
without whom this study would not have been possible. 
  
 
CONTENTS 
 
Sl.No. Title Page No. 
1. INTRODUCTION 1 
2. REVIEW OF LITERATURE 3 
3. AIM OF THE STUDY 47 
4. MATERIALS AND METHODS 49 
5. OBSERVATION AND RESULTS 55 
6. DISCUSSION 60 
7. CONCLUSION 67 
 BIBLIOGRAPHY  
 PROFORMA  
 MASTER CHART  
  
INTRODUCTION 
 Infections caused by the yeasts of the genus candida are common 
in clinical practice. They may involve the mucous membranes and / or 
skin or spread internally to produce systemic infections. 
 Superficial infections of the mucous membranes and skin are 
numerically most important but more serious involvement of the internal 
organs as in septicemia, endocarditis, meningitis, can also occur. 
 Candida albicans is an oval yeast 2-6 x 3-9 µm in size, which can 
produce budding cells, pseudohyphae and true hyphae. The ability to 
simultaneously display several morphological forms is known as 
polymorphism. Although hyphae are likely to be produced during the 
process of tissue invasion, yeasts without hyphae may also occur in 
invasive disease, particularly in infections caused by non-albicans 
candida species. 
 Candida species are normal commensals of the human beings. 
They are commonly found throughout the gastrointestinal tract, female 
genital tract and anterior urethra. They cause opportunistic infections in 
man. They have many functions inside our digestive tract and one of 
them is to recognize and destroy harmful bacteria. 
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 There are more than 200 species (1) of candida but the following 
are considered to be important pathogens for humans : Candida 
albicans, Candida tropicalis, Candida krusei, Candida guillermondii, 
Candida glabrata (now classified as Torulopsis glabrata) Candida 
parapsilosis. Candida albicans is the most commonly isolated species 
and accounts for 90% of cases of invasive Candidiasis. Trichosporon 
species which  resembles Candida krusei have recently been isolated 
from clinical specimens. Candida species are the fifth most common 
primary blood stream invaders and the seventh most common pathogen 
to cause nosocomial infections (1). 
 Candida species grow easily on Sabouraud's Dextrose Agar at 
37oC at room temperature within 24-48 hrs. The colonies are white or 
cream coloured, smooth with a yeasty odour that are naturally present as 
a part of the normal commensal in the digestive system. A problem can 
occur when there is an abnormal overgrowth of the yeast, that is 
normally controlled by the "Beneficial bacteria" in the intestines. When 
factors such as antibiotics, steroids, and refined sugar are used in excess, 
since bacteria and specific nutrients in the gut are destroyed imbalanced 
yeast can overgrow. The immune system and therefore our body's 
resistance is then lowered and the yeasts begin to invade and colonise 
the tissues. These yeasts release toxic chemicals into the blood that 
causes varying symptoms. These toxins attack the immune system, 
permitting the fungi to continue their tissue invasion and to cause more 
serious symptoms. 
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REVIEW OF LITERATURE 
 The history of Candidiasis dates back to the 4th century B.C. when 
Hippocrates, described oral aphthae (thrush) in two patients with severe 
underlying disease. Rosen Von Rosenstein in 1771 and Underwood in 
1784 recognized thrush as a condition in infants and described oral and 
gastrointestinal  thrush. In 1835, Veron first described a case of 
esophageal candidiasis and postulated that new borns acquire the disease 
during the passage through the vagina. The initial discovery of the 
thrush organism was made in 1839 by Langenbeck, who observed a 
fungus in scrapings of buccal thrush from a patient with typhus. In 1842, 
Gruby, described the thrush fungus before the academy of sciences at 
Paris as "Levrai muguet des enfants" and placed it in the genus 
Sporotrichum. 
 Two years after Gruby's report, Bennett illustrated the 
microscopic characteristics of a fungus that appeared to be Candida 
albicans in the sputum and lung of a patient who had tuberculous 
pneumothorax. In 1849, wilkinson first described vaginal Candidiasis 
and its mycotic origin, the dimorphic nature of thrush fungi was noticed 
by Grawitz in 1877. He described the budding yeast form, the mycelial 
form, and chlamydospores, although he did not name these structures. 
Ten years later, Audrey proved that the diverse morphologic forms are 
produced by the same strain, depending on environmental conditions. In 
1890, Schmorl reported a case of disseminated Candidiasis involving 
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many organs. During the following 50 years, reports followed on the 
various different forms of Candidiasis including Onychomycosis, 
Chronic mucocutaneous disease, Cystitis, Endocarditis, Osteomyelitis 
and Endophthalmitis. In 1890, Zopf named the thrush fungus Monilia 
albicans,, from which Moniliasis, the early name of Candidiasis, 
originated. As defined by Saccardo in 1886, the genus "monilia" 
included certain filamentous fungi isolated from rotting fruits and 
leaves. In 1923, Berkhout noted that the medical "Monilia" species 
differed physiologically and morphologically from the fruit-rotting 
Monilia. He established the genus Candida to accommodate "Monilia" 
and defined it to include anascosporogenous yeast species that develop 
pseudohyphae. During the first two decades of this century, Castellani 
made extensive studies on mycoses caused by yeasts. His report of 
"Tea-Taster's cough" in 1912 has been considered to be an early account 
of broncho-pulmonary candidiasis. He suggested that yeast species other 
than Monilia albicans might be involved in candidiasis and made the 
first description of the species currently known C.guillermondii, 
C.krusei, C.kefyr (C.pseudotropicalis) & C.tropicalis (2).  
 Fungal infection in human being ranges from those involving only 
the most superficial areas of the body to those in which subcutaneous 
tissue is attacked, to those deep and systemic infections that often 
involved most of the major organs of the body. The last decade has seen 
a marked increase in systemic mycoses, an increase that has been 
matched by the recent introduction of new systemic antifungal agents. 
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CHARACTERIZATION OF CANDIDA SPECIES 
 Candida Species are budding yeast like fungus and they produce 
pseudohyphae also. 
Candida albicans 
 On Sabouraud's Dextrose Agar (SDA), the colonies are cream 
coloured, pasty and smooth. In cornmeal agar at 25oC for 72 hrs, 
pseudohyphae are seen in clusters. Large thick-walled, terminal, 
chlamydospores are the characteristic of this species. They form germ 
tube on incubation with human serum. They do not produce a pellicle on 
Sabouraud's dextrose broth. 
Candida tropicalis 
 On Sabouraud's dextrose agar, the colonies are cream-coloured, 
smooth, wrinkled with mycelial fringe. On corn-meal agar, it forms 
blastospores singly or in small groups. It produces narrow surface film 
with bubbles on Sabouraud's dextrose broth. 
Candida krusei 
 On Sabouraud's dextrose agar, the colonies are dull, dry, wrinkled 
and smooth. The elongated cells have tree like arrangement or crossed 
matchsticks appearance. It produces wide pellicles on the sides of tube 
on Sabouraud's dextrose broth. Urease test is a positive reaction and is 
indicated by a purple-pink or red colour of Christensen's urease agar 
medium. 
 
 
6
Candida glabrata 
 The colonies on Sabouraud's Dextrose Agar are cream coloured, 
smooth, soft and they produce no pseudohyphae. These are small round 
or ovoid yeast cells. They are also called Torulopsis glabrata. They do 
not produce pellicles on Sabouraud's dextrose broth. 
Candida parapsilosis 
 On Sabouraud's Dextrose Agar the colonies are cream coloured, 
shiny, smooth. It produces blastospores singly or in small clusters that 
are seen along the pseudomycelium. They do not produce pellicles on 
Sabouraud's dextrose broth.  
Candida gulliermondii 
 On Sabouraud's Dextrose Agar, the colonies are thin flat, glossy, 
cream to pink, smooth or dull, wrinkled. Variable development of 
pseudomycelium that are fine and short with small cells, some times 
bearing ramified chains of small ovoid blastospores. 
Trichosporon species 
 On Sabouraud's Dextrose Agar, the colonies are creamy coloured 
moist, soft, wrinkled. They produce arthrospores, budding yeast like 
cells, and pseudohyphae are also seen. They produce wide pellicles on 
Sabouraud's dextrose broth. 
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Rhodotorula species 
 On Sabouraud's dextrose agar, the colonies are pink to red soft, 
smooth. On cornmeal - Tween 80 agar at 25oC for 72 hrs budding cells 
that are round or oval and pseudohyphae are seen. Urease test is positive 
and the reaction is indicated by a purple-pink or red colour of the 
medium. They do not produce pellicles on Sabouraud's dextrose broth. 
CANDIDA ECOLOGY AND THE COMMENSAL OR PARASITE 
ROLE (3) 
Gastrointestinal tract carriage 
 Many species of animals and birds carry yeasts, often species of 
candida in their gut as part of the normal commensal flora and the 
human is no exception. Candida albicans is a frequent but not invariable 
inhabitant of the gastrointestinal tract. Colonization occurs during birth 
directly from the birth canal, at sometime during infancy or perhaps later 
in life.  
 In his review Odds (4) concludes that fewer than 26% normal 
subjects carry yeasts in the mouth and that the figure for C.albicans 
carriage is about 18%. If specialized techniques or repeated sampling 
are used, the proportion of healthy adults carrying candida in the 
gastrointestinal tract may be demonstrably higher. 
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Vaginal carriage (5) 
 The healthy vagina may be colonized by yeasts - most commonly 
C.albicans, sometimes C.glabrata, but only in a minority of women(6). 
The percentage of vaginal carriers differs widely in different surveys, 
but a figure of 12.7% for C.albicans is probably accurate. Higher rates 
are found in hospital patients, even without vaginal disease [4]. 
Cutaneous carriage 
 Neither C.albicans nor any other species of Candida is a 
permanent member of the normal flora of the skin. At the same time, it 
is clear from numerous surveys that skin adjacent to the body orifices 
and the skin of the fingers, which are in frequent contact with the mouth, 
often yield C.albicans  and sometimes other species, particularly 
C.parapsilosis and C.guilliermondii(7). In moist intertriginous sites, 
candida may be a persistent colonizer in a few individuals. Age and 
climate are important in this connection. Samples from the very young 
and the very old are more likely to yield candida. 
Carriage in other sites 
 The bronchial tree is not normally colonized by Candida and 
whenever the organism is isolated from sputum specimens, at least in 
low amounts, it can be assumed that it has come from the mouth or 
orophanynx.  Candida albicans can occasionally be cultured from the 
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environment, usually in situations where there are heavily infected 
subjects(4). Normally however, candida is not part of the air-borne 
microflora. Except for the neonatal and conjugal infections, most of the 
cases of candidiasis probably result from infection of the host by his or 
her own commensal yeasts. Candida albicans may also demonstrate an 
unusual phenomenon known as “phenotypic switching”, whereby a 
strain may change morphology or another phenotypic character such as 
drug sensitivity in response to a change in growth conditions. Such 
changes are reversible and not associated with genetic variation (8). 
PATHOGENESIS 
Fungal virulence 
 The most common pathogen in skin disease is C.albicans, 
although increasingly other species are isolated in vaginal infections and 
from AIDS patients. 
Enzymes and Toxins 
 Factors such as the production of an acid proteinase by certain 
strains of C.albicans are also known to affect pathogenicity. Proteinase - 
negative strains are known to be less virulent (9). Laboratory - generated 
gene defective strains have not been shown to be less virulent. 
Yeast-mycelial shift (10) 
 In oral and cutaneous candidiasis, scrapings examined 
microscopically usually show candida in both budding and mycelial 
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forms. In histopathology of invasive candidiasis  hyphae are usually 
present. This suggests that the production of hyphae may contribute to 
fungal virulence. 
Adherence 
 The ability of yeast forms to adhere to the underlying epithelium 
is also an important prerequisite for tissue invasion [11-13]. Adherence 
to epithelial surface is mediated through a number of receptor 
interactions. Candida adhesins are either based on cell wall mannan or 
protein components. Among the latter is a candida surface C3d - binding 
protein [6]. It has also been shown that proteinase, production is 
necessary for adherence. 
HOST FACTORS 
 Host factors involved in mucocutaneous candidiasis are 
numerous. Any form of local tissue damage may be important in the 
pathogenesis of candidiasis. Experimental removal of the stratum 
corneum facilitates the establishment of cutaneous candidiasis and with 
a given inoculum increases the severity of the response. 
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FACTORS PREDISPOSING TO CANDIDA INFECTION 
• Mechanical factors : Trauma, local occlusion, moisture, 
maceration dentures, occlusive garments 
and obesity. 
• Nutritional factors : Avitaminosis, iron deficiency, 
generalised malnutrition. 
• Physiologic alteration : Extremes of age, pregnancy and  
menstruation. 
• Systemic illness : Down's syndrome, Acrodermatitis 
enteropathica, Diabetes mellitus and 
certain other endocrinopathies viz., 
Cushing's syndrome, hypoadrenalism, 
hypothyroidism, hypoparathyroidism. 
• Intrinsic immunodeficiency  
 States : DiGeorge's syndrome, Nezelof 
syndrome, severe combined 
immunodeficiency syndrome, 
myeloperoxidase deficiency, Chediak - 
Higashi syndrome, Hyperimmuno 
globulinemia E syndrome.  
Chronic Granulomatous Disease - AIDS 
Iatrogenic causes 
 Barrier weakening factors, indwelling catheters, I.V. drug 
abusers, X-ray irradiation. 
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Drugs 
 Corticosteroids and other immunosuppressive agents, antibiotics, 
oral-contraceptives, especially estrogen dominant, colchicine, 
phenylbutazone. 
Local tissue damage 
 The pathogenesis of candidiasis is favoured by any form of local 
tissue damage. Use of artificial dentures, favours oral candidiasis. 
Maceration and moisture favour the growth of candida on the skin. 
Studies have shown an increased incidence of candidal paronychia in 
psoriatic patients, also increased levels of candida carriage in psoriatic 
or eczematous skin. 
Role of iron 
 Iron deficiency has been found to be associated with chronic 
mucocutaneous candidiasis. However in vitro studies have shown that 
unsaturated transferrin acts as an inhibitor of Candida albicans. This 
inhibitory action is mediated via direct binding of the molecule to the 
yeast cell. Iron reverses this effect. 
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Serum Factors 
 A serum factor has been described that reduces the number of 
colony forming units by clumping but in practice it may increase the 
susceptibility to infection. Persistent candidiasis sometimes leads to the 
production of a serum factor that causes T cell inhibition. 
Endocrine Factors 
 Like diabetes mellitus, Cushing's syndrome also increases the 
susceptibility to candidiasis by suppressing the immune system. Apart 
from these, other endocrinopathies associated with candidiasis are 
Addison's disease, hypoparathyroidism and hypothyroidism that occur 
in candidal endocrinopathy syndrome. 
Immunological factors 
 Cell-mediated immunity (CMI) plays a major role though 
humoral  immunity may also have some role. Phagocytosis by  
polymorphs and macrophages is also important (14, 15). T-cell function 
is depressed in chronic mucocutaneous candidiasis, which is associated 
with the absence of specific anti-candida secretory IgA antibody (16). 
Systemic steroids increase the susceptibility to candidiasis by 
suppressing the T-cell function though topical steroids reduce the 
inflammatory reaction produced by dead and disintegrated candida cells 
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or living organism. Decreased CMI in the elderly and debilitated 
persons, in patients with Malignancies and with AIDS makes them more 
prone to mucosal or cutaneous candidiasis, but not to systemic 
infections, whereas patients with defective neutrophil / macrophage 
function are susceptible to systemic candidiasis. 
 Patients with defective T-lymphocyte function, such as those with 
AIDS, appear to be particularly susceptible to mucosal or cutaneous 
candidiasis, but not systemic infections (17). Congenitally T-cell 
deficient - mice (nu / nu ) do not show reproducible increased 
susceptibility to systemic infection by candida. In fact some 
investigators  have  found  heightened  resistance,  suggesting  that  
T-lymphocyte activity alone does not account for resistance to systemic 
invasion. In contrast, in patients with chronic mucocutaneous 
candidiasis, the most consistent abnormalities have been those of T-
lymphocyte function, particularly cytokine expression (18), even though 
some of these are now thought to be secondary to immunoregulation 
induced by the infection. 
 Patients with defective neutrophil or macrophage function are 
susceptible to both superficial and systemic candidiasis. The activity of 
neutrophils and macrophages in phagocytosis and killing of candida in-
vitro has been demonstrated. In addition some cytokines such as 
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interferon-γ appear to interact with these cells to enhance killing of the 
organism. It appears that there is therefore substantial interplay between 
different immune mechanisms in defence against candidiasis. 
CANDIDIASIS  AND  AIDS 
 In the untreated HIV - Positive population, oral candida carriage 
rates are generally high and this has been confirmed by the finding that 
carriage rates are, for instance, higher in HIV positive homosexual 
males than in a control group of HIV-negative homosexual men (1). 
Colonization rates were higher in intravenous drug abusers, Center for 
Disease Control (CDC) group IV and in those with lymphopenia. In 
addition, patients with CD4 cell depletion and those with elevated β2 
microglobulin levels were more likely to be carriers (19). 
 Oral thrush does appear to reflect viral load (20). Both hairy 
leukoplakia and oral candidiasis are markers for increased rate of 
progression to AIDS. The presence of oral candidiasis may also be a 
marker of survival in some patients. For instance, HIV positive patients 
with oral candidiasis but who have no other features of AIDS have a 
poorer survival rate than those without (21). An important factor 
implicated as a possible predisposing cause of oral candida infection in 
AIDS patients is the salivary flow rate. 
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CLINICAL SYNDROMES OF CANDIDOSIS 
Oral Candidosis (22) 
 Acute pseudomembranous candidosis  
(synonym - oral thrush) (23,24).  
Clinically characterised by a sharply defined patch of creamy, 
crumbly, curd-like white pseudomembrane, which when removed, 
leaves an underlying eyrthematous base. This membrane consists of 
desquamated epithelial cells, fibrin, leukocytes and fungal mycelium 
that attaches it to the inflamed epithelium. There may be one or many 
patches. The buccal epithelium on the cheeks, the gums or the palate 
may be affected; Tongue is also involved in the immunocompromised 
patients. It may be present in the neutropenic patient or those with AIDS 
(25-27). 
 In both cases, the clinical changes are often erosive with severe 
symptoms resulting in inadequate food intake because of pain. 
Extension of erosions to the buccal mucosa, tongue and esophagus is 
common. 
Acute erythematous candidosis (Acute atrophic oral candidiasis) (28) 
 In this condition there is marked soreness and denuded atrophic 
erythematous mucous membranes, particularly on the dorsum of the 
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tongue. It may follow pseudomembranous candidosis when traces of the 
residual membrane will often be found. It is especially associated with 
antibacterial antibiotic therapy and can also occur in HIV positive 
subjects. 
Chronic Pseudomembranous Candidosis 
 This doesn't differ clinically from the acute pseudomembranous 
variety but as the name suggests lesions are very prominent and 
persistent. It occurs principally in immunocompromised patients. 
Chronic Erythematous Candidosis (Chronic atrophic candidiasis) (29) 
 Denture sore, denture stomatitis. 
 Some soreness in the epithelium in the denture - bearing area is 
said to affect nearly one quarter of  all denture wearers. A similar 
problem may also occur in children wearing orthodontic appliances. 
 Chronic mechanical irritation and bacterial colonisation have a 
role in the pathogenesis of this condition. 
Chronic plaque like candidosis (Chronic hyperplastic candidiasis) (30) 
 Very persistent, firm, irregular white plaques occur in the mouth, 
commonly on the cheek or the tongue. Around the hyperplastic area, 
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there may be a margin of erythema. Unlike the pseudomembrane of oral 
thrush, this plaque cannot be easily removed. Serious predisposing 
factors are not present. This type has to be differentiated from other 
types of leukoplakia. Although the affected areas may undergo 
malignant (31, 32) change it may eventually clear with prolonged anti-
candida therapy. 
Chronic nodular candidosis 
 This is a rare form, where the clinical appearance that usually 
affects the tongue is of a cobbled appearance. It is most often seen in 
certain patients with chronic mucocutaneous candidosis. 
Angular cheilitis (Angular Stomatitis; Perleche ) [33]  
Soreness at the angles of the mouth extending outwards in the 
folds of the facial skin is a well known syndrome. Nutritional status and 
mechanical factors (eg. the depth of the fold), the presence of moisture 
from persistent salivation or licking the lips may also be important. The 
yeasts involved clearly come from the mouth, and the association with 
denture stomatitis is important. Although the condition may present 
acutely, it is common to find a long history of soreness and cracking at 
the angles of the mouth and a fluctuating course is typical. 
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Median rhomboid glossitis (34) 
 This condition characterised by a more or less, diamond shaped 
area on the dorsum of the tongue with loss of papillae, occurs as an 
acquired condition. It has been regarded in the past as a developmental 
abnormality, but current opinion suggests that it is simply a variant of 
chronic plaque - like candidosis. 
Candidosis, steroids and the mouth 
 Apart from systemic steroid therapy, local applications of steroids 
in the form of steroid creams, mouth washes and lozenges for the 
treatment of aphthosis or lichen planus of the mouth may predispose to 
candidosis, sometimes occurring as a secondary invasion of the primary 
pathology. Similarly, steroid aerosols, for asthma must be considered as 
at least a potential cause of diminished local immunity in this area. 
Candidosis of the skin and genital mucous membranes 
 Most cases of cutaneous candidosis occur in the skin folds or 
where occlusion from clothing or medical dressings produces 
abnormally moist conditions. Areas close to the body orifices and the 
fingers, which are frequently contaminated with saliva are also at risk. 
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Candida intertrigo (Flexural candidosis) 
  In obese subjects, any skin fold may be affected. Signs are 
typically erythema and a little moist exudation starting deep in the fold. 
As the condition develops, it spreads beyond the area of contact, usually 
developing the typical features of candidosis with a fringed irregular 
edge and subcorneal pustules rupturing to give tiny erosions and further 
peeling of the stratum corneum. Satellite lesions, pustular or papular are 
classical. Soreness and itching on occasions may be intense. In case of 
hands some abnormality including wide fat fingers, appears to 
predispose to infection. In this particular syndrome, known as Erosio 
interdigitalis blastomycetica  or interdigital candidosis, candida and 
gram negative bacteria are often co-pathogens (35). Apart from skin 
folds, macerated skin under rings and dressings may become infected 
with candida. 
 Differential diagnosis of intertriginous candiosis includes, tinea 
infection, seborrhoeic dermatitis, bacterial intertrigo, flexural psoriasis, 
Hailey-Hailey disease and flexural Darier's disease. 
Vulvovaginitis (Vulvo-vaginal thrush) (36, 37) 
 Common condition, presents with itching and soreness, and with a 
thick creamy white discharge. Most women with vaginal candidosis 
have no evidence of underlying disease. 
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 More common in pregnancy. In the non-pregnant it is said to be 
more prevalent in the premenstrual phase, but a fluctuating course not 
clearly related to the menstrual cycle is frequent. Although largely 
confined to sexually active subjects it has been described in childhood, 
sexually inexperienced and elderly people. Typically there is dusky red 
erythema of the vaginal mucosa and the vulval skin with curdy white 
flakes of discharge but on occasions the only sign is erythema. Candidial 
vulvo vaginitis may recur and in some it appears to be a chronic 
condition (38). Management of the recurrent or chronic case is difficult; 
the condition causes considerable distress. 
Candidial balanitis (39) 
 Skin of the glans penis especially in the uncircumcised, may 
sometimes be colonized by candida asymptomatically (4). 
 When candidial balanitis develops, it is usual to find either 
abundant vaginal candida carriage or frank vulvo-vaginitis in the sexual 
partner although this is variable. In the mildest cases transient tiny 
papules or pustules develop on the glans penis, a few hours after 
intercourse, and rupture leaving a peeling edge. This mild form is 
usually associated with a little soreness and irritation. In the male, 
failure to find the organism does not exclude the diagnosis if swabs or 
scrapings were not taken during the acute phase. It is wise to consider 
diabetes in cases of genital yeast infections. 
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Perianal and scrotal candidosis 
 May occur with or independently of genital involvement. 
Although usually starting around the anal margin with non-specific 
erythema, soreness and irritation subsequently spreading along the natal 
cleft is common with classical features developing as it extends. 
Candidosis must be included in the differential diagnosis of unexplained 
erythema of the scrotal skin. Secondary infection of flexural psoriasis 
with candida may have to be considered. 
Napkin candidosis (Diaper candidiasis) 
 Candida albicans is commonly isolated from the moist skin of the 
buttocks and genitalia of the infant but is more prevalent where the skin 
is affected by napkin rash (40). In some instances, the classical 
subcorneal pustules, a fringed irregular border and satellite lesions are 
found. If the bacterial flora has been suppressed by a topical antibiotic 
this will also favour the yeast. 
Nodular or granulomatous candidosis of the napkin area 
(granuloma gluteale infantum) (41, 42) 
 Clinical picture is that of a napkin eruption over the buttocks, 
genitalia, upper thighs and pubis, within which develop nodules, 
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sometimes as large as 2 cm across, bluish or brownish in colour, 
reminiscent of  Kaposi's Sarcoma.  The primary napkin dermatitis may 
clear leaving only the nodules. 
Candidial paronychia 
 Candidial species can be isolated from the majority of the cases of 
chronic paronychia (43, 44). The yeast is thought to have an etiological 
role in this condition, but bacteria and irritant or allergic contact 
dermatitis also play a part, although the contribution of each varies from 
patient to patient. Condition is common among those whose hands are 
frequently immersed in water, but in chefs and pastry cooks the presence 
of organic debris such as flour and other carbohydrates may equally be 
important. 
Clinical features  
 Typically several fingers are chronically infected, but one or all 
may be involved. The nail fold is red and swollen and there is loss of the 
cuticle, and detachment of the nail fold from the dorsal surface of the 
nail plate, leading to pocketing. 
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Onychomycosis resulting from candida 
 Erosion of the Distal and lateral  nail  plate  of  the  fingernails  
not usually progressing to total nail dystrophy has been associated with 
C-albicans invasion of the nail (DLSO) (45). Two important 
predisposing conditions are Raynaud's Phenomenon or disease and 
Cushing's syndrome. Rarely candida may invade the nail plate in the 
neonatal period, sometimes causing an isolated nail dystrophy with 
evidence of penetration of the superior aspect of the nail plate (SWO). 
Deep - seated candidiasis 
 The term 'deep-seated candidiasis' (Odds 1988, Bodey 1993, 
Edwards 1995) refers to infection of visceral organs and possibly to 
multiple organ or disseminated disease. Clinical entities include, 
candidiasis of the gastrointestinal tract, respiratory system, central 
nervous system, renal and urinary tract, cardiovascular system' 
hepatosplenic candidiasis, haematogenous disseminated disease and 
ocular infections. 
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CANDIDIASIS OF THE GASTROINTESTINAL TRACT 
Oesophagitis 
 This syndrome (Musial, Cockerill and Roberts, 1988) includes 
odynophagia and chest pains. Additional symptoms may include nausea 
and / or vomiting. White patches, which resemble those of oral 
candidiasis, can be noted by endoscopy on the esophageal mucosa. 
Oesophagitis may be associated with the presence of oral candidiasis, 
but it may also present as a separate clinical entity. The frequency of this 
syndrome has increased since the emergence of AIDS. It is estimated 
that 10-30% of AIDS patients with oral candidiasis may also have 
candidial esophagitis. This infection is also seen in cancer patients after 
anti-cancer therapy. 
GIT candidiasis 
 Candida species primarily C.albicans, C.glabrata and C.tropicalis 
colonise the gastrintestinal tract in a significant proportion of normal 
individuals (Stone et al., 1973, Bolivar and Bodey 1985, Odds 1988) as 
judged by fecal fungal isolation. An increase in percentage of colonized 
individuals is noted among the hospitalized patients. (Kusne et al., 
1994). 
 Candidal gastrointestinal colonization and infection are believed 
to play a role in the pathogenesis of disseminated candidiasis. The 
gastrointestinal tract can serve as a reservoir for the fungus, from where 
it can spread, particularly if there is a breach in the mucosal lining. 
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Candidiasis of the liver, spleen and other organs 
 Hepatosplenic candidiasis is seen primarily in individuals with 
leukemia, with hepatosplenic involvement becoming apparent during 
recovery from the neutropenic state. This clinical entity is difficult to 
diagnose and manage. Diagnosis can be assisted by Computed 
Tomography (CT) demonstrating lesions in the liver and spleen. 
Candidiasis of the respiratory system 
 Respiratory candidiasis involving the lungs or bronchial system 
appears predominantly in patients with underlying primary diseases. 
(Masur, Rosen and Armstrong 1977, Gueteau et al., 1991). 
Bronchopneumonia can originate from haematogenous spread of the 
fungus as part of a disseminated infection or from introduction of the 
pathogen into the lung. Diagnosis is difficult because candida species 
are found in the sputa of individuals without candidiasis, so that it is 
pertinent to demonstrate the presence of the fungus in 
bronchopulmonary tissues. 
Candidiasis  of the Cardiovascular system 
 Candida species can cause clinical manifestations in various 
organs of the cardiovascular system. (Musial, Cockerill and Roberts, 
1988; Kwon-Chung and Benneh, 1992, Edwards 1995). Pericardium, 
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myocardium and the endocardium can be involved with endocarditis 
being the best known clinical entity. 
Endocarditis (Hallum and Williams 1993, Wilson et al., 1993.a) is 
seen primarily in intravenous drug users and in individuals with 
impaired or prosthetic heart valves. It has also been described in patients 
after various cardiac surgery procedures or as sequelae of anti-cancer 
therapy. As a result of the increase in drug addiction and frequency of 
cardiac surgery an increase in the prevalence of candida endocarditic 
was noted. Endocarditis can be caused by C.albicans as well as 
C.parapsilosis (Cancelas et al 1994) and C.tropicalis.  
RENAL AND URINARY TRACT CANDIDIASIS  
Lower urinary tract infection 
 Candidal lower urinary tract infection (UTI) is quite frequently 
seen in association with indwelling catheters. It is seen more frequently 
in women. The infection is also found in diabetic patients (Musial, 
Cockerill and Roberts, 1988, Gentry and Price, 1993). An interesting 
clinical feature is the possible formation of fungal masses (Fungus 
balls). (Scerpella and Alhalel, 1994) which may cause obstruction and 
impair normal urine flow. 
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Renal Infection 
 Renal candidiasis can theoretically, originate from 
haematogenous dissemination of candida spp. or as an ascending UTI. 
Renal candidiasis is characterised by microabscess formation; this is 
primarily evident in the cortex of the kidneys. The kidneys are a target 
organ for the fungus in infections induced by intraperitoneal or 
intravenous inoculations. 
Central Nervous System Candidiasis 
 Involvement of the Central Nervous System (CNS) by Candida 
species is uncommon and limited predominantly to C.albicans. The most 
susceptible individuals are AIDS patients and pre-term infants. (Fakes, 
1984, Baley et al., 1986, Hughes, Lepow and Hill 1993, Edwards 1995). 
The central nervous system is generally seen as part of disseminated 
candidiasis involving, primarily the meninges, although the abscess 
formation in brain tissue has also been reported. The cells of Candida 
species may be detected microscopically in direct smears from 
Cerebrospinal Fluid (CSF). In addition abnormal protein and / or sugar 
values may be found in CSF. 
Disseminated candidiasis and candidemia 
 Can be defined as a multi-organ infection including possible 
candidemia, although blood cultures do not always yield the fungus. 
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Disseminated candidiasis caused by C.albicans and other species is 
associated with debilitation. Candidemia may present with the non-
specific symptoms of a septic state, including fever, presence of pustules 
and muscle tenderness. 
Ocular candidal infections 
 Candida species can affect both the outer and inner eye. Infection 
may originate from haematogenous dissemination or from direct fungal 
introduction. Eye involvement is caused by the following species viz., 
C.albicans, C.glabrata, C.krusei and C.parapsilosis. Endophthalmitis is 
generally a result of fungal haematogenous spread, although it may also 
result from exogenous sources, can cause total loss of vision and is 
characterised by the presence of typical white cotton-like lesions which 
as indicated are an important diagnostic criteria for disseminated 
candidiasis. 
CHRONIC MUCOCUTANEOUS CANDIDIASIS 
 Persistent candida infection of the mouth, the skin and the nails 
refractory to conventional topical therapy is a distinct syndrome 
occurring as a more or less, isolated feature. Sometimes it is associated 
with a variety of other infections, both cutaneous and systemic (46, 47). 
In the latter case, it may represent a manifestation of a primary defect in 
immune function, for example severe combined deficiency. (Swiss-type 
agammaglobulinemia). 
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Clinical Features (46) 
 But for minor variations, the syndrome consists of the following 
features, usually starting in infancy or early childhood. 
1. Persistent oral thrush responding only partially to 
conventional therapy or relapsing promptly after apparently successful 
treatment. Chronic hypertrophic changes may follow. 
2. Cutaneous Candidosis  : Often intertriginous skin is 
involved, but also the face and the hands and sometimes it is widespread 
over the trunk and limbs. In long standing lesions, the cutaneous 
changes are often atypical suggesting ringworm. Dermatophytosis in 
such patients may present in a similar manner. 
3. Paronychia is commonly a feature, often with serious nail 
plate invasion and total dystrophic onychomycosis (48). The important 
findings are nail invasion at an early age often proceeding to complete 
nail involvement. 
Patients with this syndrome comprise a heterogenous group. It is 
probably best to exclude from the syndrome of chronic mucocutaneous 
candidosis, those patients who present with a well-documented 
underlying immune defect, such as severe combined immunodeficiency 
or agammaglobulinemia, where severe candidosis may form a minor 
part of the secondary infectious complications. In these patients other 
 
 
31
serious infections such as recurrent pneumonia or aspergillosis may 
occur. 
Within the childhood onset group, there are a number of different 
variants that show features in common. Such features should not be 
taken as inflexible markers of a particular type, as there is probably 
considerable overlap in clinical expression between the different groups. 
The different types are as follows : 
1. Autosomal recessive CMC [49] 
 Usually starts in the first decade with persistent oral and nail plate 
infections. They do not develop endocrine defects and also tend to 
improve with increasing age. 
2. Autosomal dominant CMC [50] 
 Usually more severely affected, than those with the recessive 
variety and other infections such as dermatophytosis may be particularly 
troublesome. 
3. Idiopathic CMC [51] 
 This form was named diffuse CMC by Higgs and Wells in 
children who had no evidence of genetic predisposition. Their 
candidosis is also very severe with esophageal involvement and 
appearance of  'granulomas'. 
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 The term candida granuloma was originally used to describe these 
severely affected patients, who may produce sheets of hyperkeratosis 
caused by candida infection on the skin and scalp. 
4. CMC associated with endocrinopathy 
 Majority of these patients appear to have the Familial 
polyendocrinopathy syndrome [52,53]. Usually seen in early childhood, 
and occassionally the onset of the infection may predate the appearance 
of endocrine disease by as much as 10 years. Main cluster of endocrine 
abnormalities are hypoparathyroidism with hypoadrenocorticalism. 
Other autoimmunal abnormalities like pernicious anemia, vitiligo (54) 
and ovarian failure can occur. Condition is also inherited as an 
autosomal recessive condition. Another group of CMC patients with 
associated hypothyroidism has also been noted. 
5. Late onset CMC (55, 56)  
 Occasionally adult patients are found to have the syndrome of 
CMC. Cases have been associated with a thymoma, but the occasional 
sporadic infection in a patient with no detectable abnormality may be 
recognised. 
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IMMUNOLOGICAL CLASSIFICATION 
 It is still not possible to correlate precisely defects of immune 
function, with different clinical variants of the CMC syndrome and 
indeed with current investigative techniques, a substantial minority of 
cases have no demonstrable defect of immune function at all. Certain 
antigenic components of C.albicans, such as mannan as well as  some 
glycoproteins are immunomodulatory [57]. Reversal of immune defects, 
such as absent delayed - type hypersensitivity to candida antigens, has 
been with successful clearance of candidosis in CMC patients. It is 
therefore possible that some of the immunological changes may be 
secondary to the infection itself. 
DIAGNOSIS 
 The diagnosis of CMC normally requires, the elapse of time and 
repeated failure to respond to conservative treatment. Confusion may 
occur with persistent ringworm infections. A family history is of 
obvious importance and special note of full endocrine investigation is 
indicated. 
ANTIGENICITY, IMMUNE RESPONSE AND IMMUNITY 
 In defining the antigenicity of candida species, primarily that of 
candida albicans most of the studies, particularly the earlier 
investigations concentrated on the cell wall. 
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 The mannan - protein complex, particularly the polysaccharide 
moiety of the cell wall, is the major antigenic component. Antigens both 
heat labile and heat stable are present. 
IMMUNE RESPONSE 
 Exposure to candida species, stimulates, both humoral and cell 
mediated immune responses. The antibodies represent the different 
immunoglobulin types IgG, IgA, IgM or IgE. IgG and IgM are generally 
found in sera of patients with deep seated candidiasis except in highly 
immunosuppressed patients, who are unable to mount an immune 
response. IgG and IgM antibodies can also be found in the muco-
cutaneous forms of candidiasis, so that they cannot be used effectively, 
for differentiating between mucocutaneous candidiasis and deep seated 
candidiasis. 
LABORATORY DIAGNOSIS 
Direct Examination 
 Clinical specimens from diseased skin or nails can be collected by 
scraping the affected area or by the use of swabs. 
 Preferred method for direct examination of clinical specimens 
from cutaneous and nail candidiasis is the wet mount technique. 
Specimens have to be treated in most cases, with a keratinolytic 
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substance, generally 10-30% KOH, which facilitates microscopic 
examination of the specimen. 
GRAM STAIN 
 This is the most commonly used differential stain. Candida 
species are said to be Gram positive and hence they retain the colour of 
crystal violet after being treated with iodine and alcohol and hence 
candida appear purple or bluish purple. 
 Addition of Parker's ink or the lactophenol cotton blue stain, 
enhances the demonstration of fungal elements. Recent development 
involves use of calcofluor white, a fluorochrome with an affinity for 
chitin and glucan which makes demonstration of fungal elements with a 
fluorescent microscope relatively simple. 
 Direct examination of skin or nail material, reveals the oval thin-
walled yeasts bud on a narrow base, and are usually accompanied by 
filaments, either true hyphae or pseudohyphae. Presence of mycelial 
form shows colonisation and tissue invasion and therefore their 
demonstration is significant. 
CULTURE 
 The routine medium used for isolation of fungi in culture from 
mucocutaneous infections is Sabouraud's Dextrose Agar (SDA) 
supplemented with chloramphenicol, gentamicin and / or tetracycline to 
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prevent bacterial overgrowth. Candida species from mucocutaneous 
sources are relatively easily cultured. Cultures can be incubated at 37oC 
and candida colonies will be apparent within 2-3 days. In some cases 
growth will be noted after 24 hours, but it may take more than 3 days. 
 The colonies are cream coloured, smooth, pasty, dry and 
wrinkled. 
Sub-culture on indicator media 
 Chromogenic agars have now been developed that allow the 
identification of candida species. On Albicans ID agar (Bio Merieux), 
the colonies of candida albicans are blue and all other yeasts creamy or 
white. On chromagar (Becton & Dickinson), colonies of C.albicans, 
C.tropicalis and C.krusei are green, blue and pink respectively. 
 On Himedia CHROM agar various species produce the following 
colony colours. 
 Candida species   Colony colour 
Candida albicans  - Green 
Candida tropicalis  - Blue Grey or Purple 
C.glabrata   - Light Pink 
C.parapsilosis  - White, Pale Pink 
C.guillermondii  - Pale Pink, Purple 
C.krusei   - Pink , dry 
C.dubliniensis   - Dark Green 
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GERM TUBE TEST 
 The culture of candida species is inoculated into 0.5ml of sterile 
human serum and incubated at 37oC for 2-4 hours. A drop of suspension 
is examined on a slide under the microscope. The germ tubes are seen as 
long tube - like projections extending from the yeast cells (hand mirror) 
appearance. There is no constriction at the point of attachment to the 
yeast cell. 
 Germ tubes are nothing but rudimentary true hyphae. 
 Demonstration of the germ tube is also known as Reynolds - 
Braude phenomenon. The germ tube formation commonly occurs with 
candida albicans. The only other species that is germ-tube positive and 
produces vesicles on depleted media is C.dubliniensis, a yeast associated 
predominantly, with oral infections in HIV positive patients. 
CHLAMYDOSPORE FORMATION 
 The strain of candida isolate is grown on the corn meal agar with 
1% Tween 80. It shows the formation of large, highly rounded refractile 
vesicles termed chlamydospores (8-12 µm diameter), at the sides and 
ends of the filaments. These are produced within 24-96 hours of 
incubation at 26oC. 
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BIOCHEMICAL TESTS 
• The biochemical tests like sugar fermentation and assimilation are 
important for the identification of yeast isolates. 
• Sugar fermentation is being carried out with sugars like Glucose, 
maltose, Sucrose and Lactose. 
• Sugar Assimilation - Glucose, Sucrose, Maltose, Lactose, 
Galactose, Raffinose and Xylose can be used. 
SEROLOGY 
 Mannan is a major structural component of the cell wall of the 
yeasts and the principal surface antigen that is available for immune 
interaction with colonised or infected host. It is a large molecular weight 
protein polysaccharide whose carbohydrate portion consists of repeating 
mannose units in (1,6) linkage and numerous (1,2) and (1,3). 
Oligomannoside side chains. The whole cell agglutination by specific 
antisera identifies two major serotypes of candida albicans, type A and 
B and mannan comprises the type specific antigen. The serological tests 
available currently lack specificity and sensitivity. Serum antibodies and 
cell-mediated immunity are demonstrable in most people as a result of 
life long exposure to candida. In systemic candidiasis, antibody titres to 
various candidal antigens may be elevated, but there are no clear criteria 
for establishing a diagnosis serologically. 
 
 
39
ANIMAL PATHOGENECITY 
 Rabbits and mice are the most commonly used experimental 
animals in the mycology laboratory. They are susceptible to different 
species of candida. 
INDICATOR MEDIA  - Himedia CHROMagar  
 CHROM agar was founded by Dr.Alain Rambach an 
Internationally recognised microbiologist and pioneer in the field of 
Chromogenic media for the detection of pathogenic micro-organisms. 
With its headquarters and laboratory located in Paris near the Pasteur 
Institute, CHROMagar is currently developing an international sales and 
distribution network. 
 The products of Dr.Rambach's current research are "New First 
generation Chromogenic media and second generation (multicolor) 
Chromogenic media". CHROMagar Candida is a chromogenic media 
for the isolation, detection and differentiation of different Candida 
species. Yeasts produce coloured colonies within 24-48 hrs. 
 Over 95% of Candida albicans, Candida tropicalis, Candida 
krusei, Candida glabrata were correctly identified on the basis of 
colony morphology and pigmentation on CHROMagar Candida. 
CHROMagar Candida contains chloramphenicol to inhibit bacterial 
contamination. Sabouraud Dextrose Agar (SDA) is not a differential 
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medium, and colonies of different pathogenic yeast species that grow on 
this agar cannot be easily distinguished from each other. The high over 
all prevalence of yeast isolations in clinical laboratories has led earlier to 
the design of atleast three isolation media intended to differentiate 
Candida albicans from other yeasts on the basis of colony colour (58). 
 Nickerson's medium (59) which is essentially the same as the 
commercially available Biggy Agar, relies on the differential reduction 
of complex bismuth salts to give light and dark-coloured colonies. 
 Pagano et al., (60) added triphenyl tetrazolium chloride as an 
indicator to Sabouraud agar. On this medium, Candida albicans isolated 
give pale-coloured colonies, while other yeast species develop various 
shades of pink. The medium has been used successfully to reveal mixed 
yeast species in clinical isolates. 
 Costa and de Lourdes branco (61) devised a phosphomolybdate 
agar on which Candida albicans colonies are green and those of other 
species are blue. Despite the independent studies confirming the value 
of these differential isolation media, none of them has achieved wide 
acceptance for use in the routine isolation of clinically important yeasts. 
 The Pagano - Levin and phosphomolybdate agar are not currently 
available from commercial sources, and Pagano - levin medium (62) in 
practice yields a high rate of both false - positive and false-negative 
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results when used to differentiate species. Bismuth - based media do not 
adequately differentiate yeast species from each other or from bacteria 
since most organisms form colonies with a brown to black colour on this 
substrate. 
 CHROM agar Candida medium is used for the routine isolation 
and presumptive differentiation of yeasts. An indicator medium should 
exhibit several properties. It should support the growth of yeasts but not 
of bacteria. The differential property of the medium should allow 
unambiguous presumptive discrimination between the yeast species 
most commonly encountered in clinical samples and it should facilitate 
the recognition of specimens containing mixture of yeast species and 
exposure of the fungi to the differential indicator substances should not 
affect their viabilities for subsequent subculture. CHROMagar Candida 
appears to fulfill all of these requirements. 
 The new medium supported the growth of clinically isolated 
yeasts and most of the moulds (with exception being chiefly among the 
dermatophytes) but evidently retards the growth of bacteria. The 
viability of fungi grown on CHROMagar candida is not affected by 
exposure to the medium, and the medium affords an extremely high 
level of discrimination among the most commonly isolated yeast 
species. The colour differential between C.albicans, C.krusei, 
C.tropicalis and most other species is much more striking than that seen 
 
 
42
with previous differential yeast media (Nickerson's medium, Pango-
Levin medium) with Himedia CHROMagar. The performance of 
CHROMagar Candida exactly paralleled that of Sabouraud glucose agar 
in terms of its ability to support the isolation of yeasts from clinical 
samples.  
TREATMENT 
 The fungal infections these days are becoming very common not 
only as primary diseases but secondary to various predisposing factors. 
Moreover, it is very difficult to treat these infections particularly among 
the immunocompromised individuals. Though there have been multiple 
antifungal agents developed so for, only a few are clinically effective. 
There are many obstacles in the management of fungal diseases by these 
agents. Due to the eukaryotic nature of both fungal and human cells, 
their metabolism resembles significantly with each other. Therefore any 
antifungal drug inhibiting particular metabolic activity will be toxic for 
use by human beings also. There is poor penetration of the drug in the 
tissue because the fungi infect relatively poorly vascularised areas. 
Moreover, slow growth of fungi and the granulomatous response of host 
tissue also make the drug less penetrable to reach the target sites. The 
efficacy of the treatment of fungal infections is dependent on several 
factors. 
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1. Drug factors such as potency of the drug tissue penetration and 
distribution within the body. 
2. Organism factors such as virulence, susceptibility to a given drug 
and development of resistance and 
3. Host factors such as underlying immune status including the 
alteration of the normal mucosal flora, neutropenia and humoral 
and cellular immunity. 
 Based on the source, the antifungal agents are divided into the 
following groups. 
 1. Antifungal Antibiotics 
 2. Synthetic Antifungal Agents 
ANTIFUNGAL ANTIBIOTICS 
 Polyenes 
  a. Amphotericin B 
  b. Nystatin 
SYNTHETIC ANTIFUNGAL AGENTS 
 Azoles 
  a. Fluconazole 
  b. Itraconazole 
  c. Ketoconazole 
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 Thrush and other mucocutaneous forms of candidiasis are usually 
treated with topical or systemic Nystatin, Fluconazole and 
Ketoconazole. Systemic candidiasis is treated with Amphotericin B, 
sometimes in conjunction with oral flucytosine. Chronic mucocutaneous 
candidiasis responds well to Ketoconazole and other azoles, but patients 
who have a genetic defect often require life - long treatment (63 & 64). 
ANTIFUNGAL AGENTS 
Amphotericin B 
 This is a broad - spectrum polyene antibiotic which is obtained 
from Streptomyces nodosus. It has greater affinity for ergosterol than 
cholesterol, the latter being the predominant sterol in the mammalian 
cell wall. The pores formed by Amphotericin B increases permeability 
so that essential molecules leak from the cytoplasm and fungal growth is 
inhibited. It is insoluble in water and unstable at 37oC. It is a potentially 
effective fungicidal drug. 
 The intravenous route of Amphotericin B remains the gold 
standard of therapy for most of the fungal diseases. Amphotericin B is 
available in 50mg vial as deoxycholate Amphotericin B suspension. It is 
not absorbed after oral intake and hence, given through intravenous 
infusions in 5% dextrose over 2-4 hours. Intrathecal injections may also 
be given in case of fungal meningitis. The usual dose is 0.4 - 0.6 mg/kg/ 
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day. The total dose should not exceed 2.0-2.5gm. The side effects of this 
drug restricts its uses, it is known for its nephrotoxicity. There may be 
headache, chills, fever, severe hemolytic anaemia, hypokalemia and 
nephritis. 
NYSTATIN 
 Like Amphotericin B, Nystatin also belongs to the group of 
polyene antibiotic and it is obtained from Streptomyces noursei. It 
combines with the fungal cell membrane and interferes with vital 
cellular processes like respiration and glucose utilisation. Nystatin 
exhibits both fungistatic and fungicidal activity depending on the drug 
concentration, the susceptibility of the fungus, presence of blood. 
TRIAZOLES 
Fluconazole 
 This triazole derivative has proper water solubility, oral 
absorption, extensive bioavailability independent of food or pH, least 
protein binding and a sufficiently long half-life to allow once-a-day 
administration. It penetrates readily into CSF and is excreted unchanged 
in urine and feces being metabolically stable with recovery of over most 
of the administered dose. 
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Itraconazole 
 This triazole compound has been found superior to other azoles in 
several respects. It was first synthesized in 1980. It has better 
distribution in tissues and its expanded half - life is 15-24 hours. This is 
a lipophilic compound characterized by good absorption in all tissues 
except CSF. 
NEW ANTIFUNGAL AGENTS 
 The new antifungal agents fall into several groups or drug classes. 
There are the triazoles, which include Posaconazole,  Ravuconazole,  
and  Voriconazole.  Another  class  of  new  agents   is  the  Candins,  
the   beta - Glucan  synthase  inhibitors.  Included  are :  (1) 
Caspofungin,  (2) Echinocandin and (3) FK463 (micafungin); 
Liposomal Nystatin (Nyotran) belongs to the polyene class of antifungal 
drugs. 
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AIM AND OBJECTIVE OF THE STUDY 
BACKGROUND 
 The term immunocompromised host is used to define a patient 
with impaired host defences who is at the risk of developing an 
opportunistic infection. This includes patients with immunodeficiency 
because of the disease perse such as patients with ‘Acquired Immune 
Deficiency Syndrome’ (AIDS) or induced iatrogenically as a result of 
chemotherapy. Susceptibility to infection is increased when normal host 
defence mechanisms are compromised by underlying disease states, 
therapeutic interventions or iatrogenic manipulations. Frequently all the 
three factors play a role in creating an immunocompromised state, in 
which infection is likely. Candida species are the most common cause of 
systemic fungal infections in the immunocompromised patients 
(Hawkins, 1984). 
 This study has been designed, 
1. To isolate, culture and subculture thereby identify the subspecies 
of candida from the mucosal lesions of immunocompromised 
individuals. 
2. To study the age and sex distribution of immunosuppressed 
patients suffering from candidiasis. 
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3. To study the morphological pattern of lesions in the background 
of immunosuppression. 
4. To identify the subspecies of candida causing various types of 
lesions in immunosuppressed patients. 
5. To study the dose and duration of the immunosuppressive therapy 
that predisposed to candidasis. 
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MATERIALS AND METHODS 
This study was conducted at the Government General Hospital, 
Chennai. 
One hundred and Twenty (120) patients who were either on 
immunosuppressive therapy or suffering from acquired 
immunodeficiency states, attending, The Department of Dermatology 
were screened for the present study. Study was carried out from 1st July 
2006 to 30th September 2007. Cases were included in the study after 
confirming their diagnosis through appropriate investigations including 
histopathological studies and serological studies. 
INCLUSION CRITERIA 
1. Patients should have cutaneous manifestations related to the 
disease with which they are suffering from  
2. Patients should have either been instituted therapy with systemic 
immunosuppressive drugs for the management of their disorders 
or should suffer from immunodeficiency because of the disease 
perse. 
3. Development of candidiasis should be after the institution of 
immunosuppressive therapy. 
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EXCLUSION CRITERIA 
1. Patients below 12 years of age. 
2. Pregnant women 
3. Patients who have taken Anti-fungal treatment (topical / systemic) 
within the past 6 months. 
4. Patients with biological false positive serological tests. 
BREAK-UP DETAILS OF PATIENTS ARE AS GIVEN BELOW 
Break-Up details of patients Diagnosis-Wise  
and Gender-Wise Screened for Candidiasis 
Table - 1 
Clinical Entity Male Female Total 
Pemphigus Vulgaris 07 18 25 
Bullous Pemphigoid 08 03 11 
Pemphigus Vegetans 02 03 05 
Pemphigus foliaceus 03 03 06 
Dermatitis Herpetiformis 02 0 02 
Toxic Epidermal Necrolysis 02 01 03 
Behcet’s Syndrome 0 01 01 
Lichen Planus 02 0 02 
Systemic Lupus Erythematosus 01 03 04 
Psoriasis 05 03 08 
Diabetes Mellitus 02 0 02 
Renal transplantation 02 0 02 
HIV / AIDS 37 12 49 
Total 73 47 120 
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 Detailed case history of each patient was collected with reference 
to the duration of primary disease for which the immunosuppressive 
drug was given; appropriate note was also made regarding the dose and 
duration of each drug in their immunosuppressive regime. 
 Site, symptomatology and the duration of candidial infection that 
appeared after immunosuppressive therapy were recorded.  
 Detailed examination was also done to note down the other 
dermatological lesions. 
MYCOLOGICAL EXAMINATION 
 Specimens such as mucosal scrapings were collected under 
aseptic precautions and examined microscopically in 10% potassium 
hydroxide (KOH) solution for the presence of fungal elements. 
 Whenever the scraping was positive for budding yeast cells, 
hyphae or pseudohyphae, inoculation was done on Sabouraud’s 
Dextrose Agar (SDA) (Media of pH 6.5) with chloramphenicol 
(0.05mg/ml). Duplicate slants were maintained for all specimen. 
 All the inoculated slants were duly numbered and incubated at 
37oC for a period of 24-48 hours, with everyday observation. Candida 
colonies appeared as white or cream coloured, smooth with a yeasty  
odour. 
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SABOURAUD’S DEXTROSE AGAR 
MEDIA PREPARATION 
Ingredients : 
 Dextrose  - 2g 
 Peptone - 1g 
 Agar - 2g 
 Distilled water  - 100 ml 
 pH - 6.5 
 The ingredients are weighed accurately and then dissolved in 
100ml of distilled water. Its then warmed gently till the boiling point of 
water so that agar dissolves completely and the solution becomes 
homogenous. When the media has become transparent warming up is 
stopped. 
 The media is sterilized by autoclaving at 15 lbs pressure (121oC) 
for 15 mts. 
 Antibiotic chloramphenicol is added (0.05mg/ml); sterilized 
media is then allowed to cool to 50oC and then poured into sterile test 
tubes and then kept in appropriate inclination for the bud and slant 
formation. After a time lag of 4-6 hours the media is ready for 
inoculation. 
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SUB-CULTURE MEDIA  →  INDICATOR MEDIA 
Hicrome Candida Agar 
Hicrome candida agar is recommended for rapid isolation and 
identification of candida species from mixed cultures. 
Composition 
 Ingredients    Grams / Litre 
 
 Peptic Digest of animal tissue   15.0 
 Agar       15.0 
 Chloramphenicol       0.5 
 Chromogenic mixture    11.22 
 Dipotassium hydrogen phosphate    1.0 
 Final pH (at 25oC)     6.3 ±  0.2 
Constitution of Media 
 21.36 gms of Hicrome candida agar is dissolved in 500 ml of 
distilled water. It is allowed to boil to dissolve the medium completely. 
Media should not be autoclaved. Media is then cooled to 50oC and 
aseptically poured into sterile petri plates. 
Subculture 
 Subculture of candida from SDA in Hicrome candida agar is done 
after 24-48 hours of primary culture. 
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Principle and interpretation 
 Perry and Miller (65) reported that candida albicans produces an 
enzyme  β-N-acetylgalactosaminidase and according to Rousselle et al.,  
(66) incorporation of chromogenic or fluorogenic hexosaminidase 
substrates into the growth media helps in identification of candida 
albicans isolates directly on primary isolation. Hicrome candida agar 
media are selective and differential medium which facilitates rapid 
isolation of yeasts from mixed cultures and allows differentiation on the 
basis of colouration and colony morphology. 
 Peptic digest of animal tissue, yeast extract, malt extract and 
glucose provides nitrogenous, carbonaceous, compounds and other 
essential growth nutrients. Chloramphenicol suppresses bacteria. 
Cultural response 
Organisms  Colour 
C.albicans - Light green 
C.tropicalis - Light blue 
C.krusei - White fuzzy 
C.glabrata - Light pink 
C.dubliniensis - Dark green 
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OBSERVATION AND RESULTS 
 
 Out of 120 patients with immunosuppression subjected for the 
screening of candidiasis, 100 patients only were positive for candidiasis 
which includes 62 males and 38 females (Table - 2). Their age ranged 
from 17 years to 85 years with a mean of 41.6 years. 
Age and Gender Distribution of cases positive for candidiasis 
Table - 2 
No.of Cases Age Group 
(Years) Male Female 
Total No.of 
cases 
10 - 20 02 00 02 
21 - 30 09 13 22 
31 - 40 20 10 30 
41 - 50 15 08 23 
51 - 60 06 04 10 
61 - 70 09 02 11 
71 - 80 00 01 01 
81 - 90 01 00 01 
Total 62 38 100 
 
 
 Both the patients in the extremes of age were males. The 
maximum number of Males (20) were in the age group of 31-40 years 
and maximum number of Females (13) were in the age group 21-30 
years. The duration of their skin disease ranged from 3 weeks to  
10 years.  
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 Out of the 100 patients positive for candidiasis, 60 patients 
suffered from various dermatological entities among which pemphigus 
vulgaris patients top the list (24) cases. The remaining 40 patients were 
victims of HIV. 
 Pemphigus vulgaris was the commonest bullous disorder that 
accounted for oral candidosis (40%).  
 Distribution of candidiasis in relation to various dermatoses on 
immunosuppressive therapy is as given below. 
Distribution of candidiasis in relation to various dermatoses on 
immunosuppressive therapy or immunocompromised status 
Table - 3 
Clinical Entity Male Female Total 
Pemphigus Vulgaris 06 18 24 
Bullous Pemphigoid 08 02 10 
Pemphigus Vegetans 01 02 03 
Pemphigus foliaceus 03 02 05 
Dermatitis Herpetiformis 01 0 01 
Toxic Epidermal Necrolysis 01 0 01 
Behcet’s syndrome 0 01 01 
Lichen Planus 02 0 02 
Systemic Lupus 
Erythematosus 01 03 04 
Psoriasis 04 01 05 
Diabetes Mellitus 02 0 02 
Renal transplantation 02 0 02 
HIV / AIDS 31 09 40 
Total 62 38 100 
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Distribution of candidiasis in relation to various  
dermatoses percentage wise 
Table - 4 
(n = 60) 
Primary Dermatoses % of cases 
Pemphigus vulgaris 40% 
Bullous pemphigoid 16.6% 
Pemphigus foliaceus 8.3% 
Psoriasis 8.3% 
Pemphigus vegetans 5% 
SLE 6.6% 
Lichen planus 3.3% 
Diabetes mellitus 3.3% 
Renal transplant 3.3% 
Dermatitis herpetiformis 1.6% 
Behcet’s syndrome 1.6% 
Toxic epidermal necrolysis 1.6% 
 
Duration and drug regime of immunosuppressive therapy 
 The duration of the therapy that predisposed to candidosis ranged 
from 10 days to 1 year. 
 Out of 100 patients, positive for candidiasis 28 patients had taken 
treatment with Tab. Prednisolone 5mg alone taken in a dose range of 
15mg to 20mg per day. 
 
 
58
 22 patients were treated with Inj. Dexamethasone (8 mg) 
 5 patients were on Tab. Methotrexate 7.5mg/week. 
 2 patients were on combination of drugs viz., 
Inj. Dexamethasone (100 mg) &  
 Inj. Cyclophosphamide (500 mg) (DCP) Pulse therapy. 
Other combination of immunosuppressive drugs used were : 
 T. Predinisolone (15 mg) + Azathioprine (50 mg). 
MORPHOLOGY OF THE COLONIES 
 After inoculation of the material under sterile aseptic precautions, 
in SDA culture tubes with chloramphericol, tubes were incubated at 
37oC. Creamy white, smooth individual colonies of candida with a 
yeasty odour were observed after 24-48 hours. 
 Individual colonies could be appreciated standing out as dome 
shaped growth till 48-72 hours, since the time of inoculation, after 
which the culture gets contaminated with saprophytic bacteria and other 
yeasts and moulds. 
 Subculture was made into Hicrome candida agar under sterile 
aseptic precautions and colonies were observed after 24-48 hours. 
Species of candida were identified with the help of the colour that they 
have produced by their interaction with the chromogenic indicator 
incorporated in the Himedia ChromAgar. 
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The following were the colours produced by difference species of 
candida. 
Organisms  Colour 
C.albicans - Light green 
C.tropicalis - Light blue 
C.krusei - White fuzzy 
C.glabrata - Light pink 
C.dubliniensis - Dark green 
 
 Even the subculture gets contaminated after 24-48 hours after 
inoculation and hence meticulous care was taken to read the colours at 
the end of 48 hours, as the colours produced by various species gets 
altered because of the contaminant growth. 
Germ tube formation 
 Species of candida albicans were inoculated into 0.5ml of sterile 
human serum at 37oC and incubated for 2-4 hours. When a drop of 
culture was examined under the high power of Microscope, candidia 
albicans species revealed ‘germ-tube’ formation, which is nothing but 
rudimentary hyphae attached to the budding yeast cell without 
constriction at the point of attachment, which resembled that of “Hand-
mirror appearance”. 
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DISCUSSION 
 In our present study of candidiasis, out of the 100 cases positive 
for candidiasis included, majority of the patients were found to be in the 
age group of 31-50 years (53%); out of which 35 were male patients, 
and 18 were female patients. Patients in the extremes of age were males. 
The youngest male patient with oral candidiasis was a case of Bullous 
pemphigoid of age 17 years. The eldest patient was again a male of age 
85 years, who was suffering from bullous pemphigoid. 
 Out of the 100 cases included in this study, 60 patients had 
various dermatoses and 40 cases were victims of HIV infection. 
 Of the 60 patients, with various dermatoses studied, pemphigus 
vulgaris was the commonest clinical entity to be associated with oral 
candidosis. 
 24 cases of pemphigus vulgaris had oral candidosis in our study 
(40%). The next common bullous disorder to be associated with 
candidosis was bullous pemphigoid. 10 cases of bullous pemphigoid had 
oral candidosis amounting to 16.6%. 
 Incidence of oral candidosis is more in pemphigus vulgaris than 
bullous pemphigoid because of the fact, that nearly 70% of the cases of 
pemphigus vulgaris  have oral lesions, whereas only 30% of the Bullous 
pemphigoid cases present with oral lesions. 
 
 
61
 Other dermatoses to be associated with oral candidiasis in the 
decreasing order of frequency were,  
Pemphigus foliaceus (8.3%), Psoriasis (8.3%), Pemphigus 
vegetans (5%), SLE (6.6%), Lichen planus (3.3%), Dermatitis 
Herpetiformis (1.6%), TEN (1.6%)  and Behcet’s Syndrome (1.6%). 
 Diabetes Mellitus was associated with candidosis to an extent of 
3.3%.  
2 male patients had diabetic balanoposthitis. Post renal transplant 
patients on immunosuppressive therapy were associated with oral 
candidosis to an extent of 3.3%. 
IMMUNOSUPPRESSIVE DRUG 
 In the present study the immunosuppressive drug commonly used 
was prednisolone, either alone or in combination with azathioprine or 
cyclophosphamide. The period of immunosuppressive therapy needed to 
produce candidosis infection of the mucosal surfaces varies from a 
minimum of 10 days to maximum of 1 year. Combination of 
immunosuppressive drugs leads to persistence of candidial infection. 
MORPHOLOGICAL TYPES OF THE LESION 
 In patients with bullous disorders who were on systemic steroids 
and other cytotoxic drugs like cyclophosphamide, azathioprine etc.  the 
commonest type of oral candidosis encountered was acute 
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pseudomembranous candidiasis, (Thrush) characterized clinically by 
a sharply defined patch of creamy, crumbly, curd like white 
pseudomembrane, which when removed leaves an underlying 
erythematous base. The clinical changes were of the erosive type with 
severe symptoms resulting in inadequate food intake because of pain. 
(Photo No.1) 
 Acute erythematous candidosis was the second commonest type 
of candidosis that was encountered in our study. Marked soreness and 
denuded atrophic erythematous mucous membranes were noticed on the 
dorsal aspect of the tongue. This type  might follow pseudomembranous 
candidiasis (Photo No.2). 
Angular cheilitis (Perleche) 
 Soreness at the angles of the mouth extending outwards in the 
folds of the facial skin was noticed in all the patients of bullous 
dermatoses apart from their thrush lesions (Photo No.3). 
Median rhomboid glossitis 
 Median rhomboid glossitis type of candida lesion was 
encountered in one HIV infected male patient of age 40 years who was 
on antiretroviral therapy; condition was characterized clinically by a 
more or less diamond shaped area on the dorsum of the tongue with loss 
of papillae (Photo No.4). 
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 In cases of chronic oral candidosis deep fissuring of the tongue 
in a cerebriform pattern was noticed in a female patient suffering from 
pemphigus vulgaris (Photo No.5). 
 In patients with HIV infection deep longitudinal midline fissuring 
of the tongue was noticed (Photo No.6). 
 Majority of the male patients with HIV infection, with oral 
candidiasis had addisonian type of oral pigmentation involving the hard 
and soft palates and also the buccal mucosa irrespective of  
their smoking habits. In HIV patients with CD4 count less than  
100 cells/Cu.mm, candidial patches were also noticed in the hard and 
soft palate apart from the lesions over the tongue (Photo No.7). 
 The black pigmentation persisted even after the clinical cure of 
the lesions (Photo No.8). 
 A female patient with HIV infection had multi-dermatomal herpes 
zoster as an associated dermatological entity (Photo No.9). 
 In Diabetic individuals candidial balanoposthitis was associated 
with soddening and linear fissuring;  prepuce  was  edematous  and  
there was subprepucial discharge because of the associated phimosis 
(Photo No.10). 
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  The following species of candida, were isolated on doing 
subculture in Himedia CHROMagar, viz., 
 Candida albicans (52%), C.tropicalis (22%), C.glabrata (21%), 
C.krusei (3%) and C.dubliniensis (2%), (Fig.No.5). 
 Candia albicans was the commonest species isolated both from 
HIV (27) and Non-HIV (25) infected individuals. 
 Germ tube formation (Reynolds-Braude) phenomenon was 
positive in candida albicans on incubation with human serum at 37oC 
after 2-4 hours (Photo No.11). ‘Fringe of pseudohyphae’ formation was 
there around the edge of the colony in cultures of candida albicans 
(Photo No.12). 
 Candida dubliniensis was isolated from the oral lesions of two 
HIV positive patients. C.dubliniensis produces dark green colour in 
Himedia - CHROMagar (Photo No.13). 
 In the female patient with C.dubliniensis infection the CD4 count 
was less than 50 cells / cu.mm and the patient had verruca vulgaris as an 
associated opportunistic infection. Acute pseudomembranous glossitis 
was the clinical type of lesion in this patient. 
 The commonest systemic disease associated with HIV patients 
with oral candidosis was pulmonary tuberculosis. 
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 Few patients (2) also had associated tuberculous abdomen and 
pleural effusion. 
 Extensive Dermatophyte infections, Eosinophilic folliculitis, 
Pyrexia of Unknown Origin (PUO) and seborrhoeic dermatitis were the 
other associated conditions found in HIV patients.  
Acneiform eruptions, skin tags, thyrotoxicosis, cortical cataract, 
photosensitivity, xerosis, folliculitis were the associated entities 
encountered in Non-HIV patients. 
Candidiasis is the commonest mycosis in patients on systemic 
immunosuppressive therapy / immunosuppressed status (Dreizen et al., 
1992)  (67), Hawkins et al., 1984 (68). In symptomatic patients with 
candidiasis, minimum period of immunosuppressive therapy required 
was 10 days in a female patient with pemphigus vulgaris (age : 45 years) 
who was on parenteral steroid therapy, which is little earlier compared 
to the study by Rubin et al., in 1981. 
The clinical type of candidiasis  was  pseudomembranous  
glossitis in the majority of patients as also reported in other studies 
(Prentice, 1989). 
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Disseminated candidiasis was not seen in any of the patients in 
this study, since dissemination is expected only with defects in the 
polymorphonuclear leucocyte and not with the T cell suppression alone 
which occurs commonly with immunosuppressive therapy. 
Out of the 100 patients positive for candidosis, diabetes mellitus 
was found in 16 patients; of these sixteen patients (6 patients were 
females and 10 were males), Diabetes mellitus was exclusively present 
in only 2 male patients as a predisposing factor for candidosis 
(Balanoposthitis) whereas in the remaining 14 patients primary 
dermatoses like bullous disorders and immunosuppression due to HIV 
infection were the main predisposing factors for candidial infection, and 
diabetes mellitus was just an added factor for predisposition. 
 Highest incidence of  ‘O’+ve blood group was noticed in majority 
of the patients with candidiasis in our study; this was followed by B+ve 
which is similar to the occurrence in general population, although 
people with O+ve Blood group are considered to have high carriage of 
candida species. 
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SUMMARY AND CONCLUSIONS 
• Candidiasis is the commonest mycosis in patients on systemic 
immunosuppressive therapy and immunosuppressive status like 
HIV infection. 
• Majority of the affected victims of candidiasis, were in the  
age group between 31-50 years. Incidence of candidiasis   
was found to be more in male patients than female patients.  
(Males → 62%). (Females → 38%). However the age and sex 
distribution is also related to the patients screened. 
• Acute pseudomembranous glossitis was the commonest 
morphological type of the lesion encountered in this study (35%), 
to be followed by, chronic erythematous candidiasis (22%), 
Angular cheilitis (21%), acute erythematous glossitis (19%), 
balanoposthitis (2%) & Median rhomboid glossitis (1%). 
• Among the various immunosuppressive drugs taken into account 
for this study, Tab.Prednisolone was the commonest  
drug predisposing to candidiasis (28%) followed by  
Inj. Dexamethasone (22%). Thus systemic steroids accounted for 
50% of drugs predisposing to candidosis, remaining 50% being 
contributed by cytotoxic drugs like methotrexate, 
cyclophosphamide, azathioprine etc; 
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• Of all the various bullous dermatoses screened, pemphigus 
vulgaris was the commonest bullous disorder predisposing to 
candidosis (40%) followed by bullous pemphigoid (16.6%), 
Pemphigus foliaceus (8.3%), Dermatitis Herpetiformis (1.6%) and 
Pemphigus vegetans (5%). 
• Candida albicans was the commonest species isolated (52%). 
Other species isolated include, 
Candida tropicalis (22%), Candida glabrata (21%), Candida 
krusei (3%) and Candida dubliniensis (2%). 
• Patients with O+ve Blood group are considered to have high 
carriage of candidia species. 
• Even in HIV infected individuals, candida albicans was the 
commonest species isolated, in our study; candida dubliniensis is 
said to be exclusively common in the oral lesions of HIV patients, 
which however accounted only for (2%) in our study. Probably 
the sample size had still been larger. 
• The minimum time duration of systemic immunosuppressive 
therapy required for predisposition to oral candidosis was found 
to be 10 (Ten) days in our study in Non-HIV infected individuals, 
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which was found to be still shorter in known cases of HIV 
infection (around 1 week); probably due to CD4 cell count 
depletion, and other associated opportunistic infections. 
• Inspite of heroic measures to avoid contaminants, and adhering to 
very strict aseptic protocols, it was found in our study that the 
maximum keeping time of primary candida culture in SDA with 
chloramphenicol and subcultures in Himedia CHROMagar was 
just 72 hours, after which saprophytic bacteria and various 
moulds and concomitant pathogens spoil the culture media. 
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 PROFORMA 
Sl.No. 
Name :       O.P.No. : 
Age :    Sex : M/F  Date    : 
Chief Complacints : 
Duration  : 
Family History : 
Marital History : 
Predisposing Factors : 
 Diabetes 
 Tuberculosis 
 Immunosuppressive Therapy 
 HIV 
 Pregnancy 
 Malnutrition 
 Endocrine Causes 
 Systemic Illness 
 Iatrogenic Causes 
Associated dermatological disorders : 
    Acne 
    Sebderm 
    Psoriasis 
    Lichen Planus 
    Dermatophyte Infection 
    Acanthosis Nigricans 
    Other Dermatological Conditions 
 General Examination : 
    Anemia 
    Obesity   Weight 
    Avitaminosis 
    Diet - Nutritional Status 
    Pregnancy 
    TB 
Systemic Examination 
    CVS 
    RS 
    Abdomen 
    CNS 
    Others 
Dermatological Examination 
    Site of the lesion 
    Type of the lesion 
    Cutaneous (or) Mucocutaneous 
INVESTIGATIONS 
1. Routine Haemogram 
2. Scraping / Swab (KOH examination) 
3. Special stains 
4. Culture and Subculture 
5. Blood grouping & Typing 
6. Blood VDRL 
7. HIV ELISA 
8. Blood Sugar 
9. Endocrine Assessment 
